UCHL1 appears, therefore, to reflect an earlier biochemical milieu, occurring before the onset of overt neurodegeneration that characterizes the peri‐symptomatic phase of ALS and FTD. This evidence concerns the gene UCHL1 and amyotrophic lateral sclerosis.